Endurant Capital Management LP Abb Vie Inc. Transaction History

Endurant Capital Management LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $19.4 Million - $24.5 Million	-180,429 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $10.1 Million - $11.5 Million	94,915 Added 110.99%	180,429 $19.5 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $259,658 - $289,274	-2,468 Reduced 2.81%	85,514 $9.63 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $351,707 - $387,187	3,438 Added 4.07%	87,982 $9.52 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $9.21 Million - $12.4 Million	-114,377 Reduced 57.5%	84,544 $9.06 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $11.7 Million - $13.7 Million	136,306 Added 217.69%	198,921 $17.4 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $4.59 Million - $6.15 Million	62,615 New	62,615 $6.15 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $6.36 Million - $9.64 Million	-98,596 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $4.57 Million - $5.72 Million	-63,411 Reduced 39.14%	98,596 $8.73 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $4.6 Million - $5.53 Million	72,999 Added 82.01%	162,007 $12.3 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $4.42 Million - $5.65 Million	67,334 Added 310.67%	89,008 $6.47 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $1.67 Million - $1.97 Million	21,674 New	21,674 $1.75 Million

3,869

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $302B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.